Advanced Medical Solutions Grp PLC Results of Annual General Meeting (2092B)

TIDMAMS

RNS Number : 2092B

Advanced Medical Solutions Grp PLC

31 May 2023

31 May 2023

Advanced Medical Solutions Group plc

("AMS" or the "Group")

Results of Annual General Meeting

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the world-leading specialist in tissue-healing technologies , announces that at the Company's Annual General Meeting held today at 11 am at the Offices of Investec Bank plc, 30 Gresham Street, London, EC2V 7QP, all resolutions were duly passed. Further details of each of the resolutions are set out in the Notice of Meeting, which was sent to shareholders on 28 April 2023.

The poll results were as follows .

 
 Resolution   Title            For               For       Against               Against   Total              % Issued 
                                                  %                               %         Votes              Capital 
              FINANCIAL 
 1             STATEMENTS          135,930,178   100.00%                2,600      0.00%        135,932,778     62.61% 
             --------------  -----------------  --------  --------------------  --------  -----------------  --------- 
              REMUNERATION 
 2             REPORT              134,448,331    98.78%          1,660,110        1.22%        136,108,441     62.69% 
             --------------  -----------------  --------  --------------------  --------  -----------------  --------- 
              AUDITOR 
 3            REMUNERATION         129,945,308    95.88%          5,579,727        4.12%        135,525,035     62.42% 
             --------------  -----------------  --------  --------------------  --------  -----------------  --------- 
              RE-ELECT P 
 4             ALLEN               121,131,315    88.99%        14,989,308        11.01%        136,120,623     62.70% 
             --------------  -----------------  --------  --------------------  --------  -----------------  --------- 
              RE-ELECT G 
 5             COOK                123,309,347    90.59%        12,804,964         9.41%        136,114,311     62.69% 
             --------------  -----------------  --------  --------------------  --------  -----------------  --------- 
              RE-ELECT D 
 6             LE FORT             123,977,756    91.08%        12,136,555         8.92%        136,114,311     62.69% 
             --------------  -----------------  --------  --------------------  --------  -----------------  --------- 
              ELECT L 
 7            SHANAHAN             136,068,717    99.97%               45,594      0.03%        136,114,311     62.69% 
             --------------  -----------------  --------  --------------------  --------  -----------------  --------- 
              RE-ELECT C 
 8             MEREDITH            131,687,725    96.74%          4,434,124        3.26%        136,121,849     62.70% 
             --------------  -----------------  --------  --------------------  --------  -----------------  --------- 
              RE-ELECT E 
 9             JOHNSON             133,113,126    97.80%          3,001,185        2.20%        136,114,311     62.69% 
             --------------  -----------------  --------  --------------------  --------  -----------------  --------- 
              FINAL 
 10           DIVIDEND             136,127,581   100.00%                   278     0.00%        136,127,859     62.70% 
             --------------  -----------------  --------  --------------------  --------  -----------------  --------- 
 11           ALLOT SHARES*        135,448,934    99.52%             654,222       0.48%        136,103,156     62.69% 
             --------------  -----------------  --------  --------------------  --------  -----------------  --------- 
              PRE-EMPTION 
 12            RIGHTS*             129,949,465    95.47%          6,165,524        4.53%        136,114,989     62.69% 
             --------------  -----------------  --------  --------------------  --------  -----------------  --------- 
              PURCHASE 
 13           SHARES*              135,042,435    99.95%               63,012      0.05%        135,105,447     62.23% 
             --------------  -----------------  --------  --------------------  --------  -----------------  --------- 
 

* Special Resolution

 
 Notes: 
  1. Votes "For" and "Against" are expressed as a percentage of votes 
  received. 
  2. A "Vote withheld" is not a vote in law and is not counted in 
  the calculation of the votes "For" or "Against" a resolution. 
  3. Total number of shares in issue at close of business on 26 M 
  ay = 217,109,419 shares. 62.63% of the voting capital was instructed. 
 

- Ends -

For further information, please visit www.admedsol.com or contact:

 
 Advanced Medical Solutions Group plc            Tel: [phone] 
                                                            545508 
 Chris Meredith, Chief Executive Officer 
  Eddie Johnson, Chief Financial Officer 
  Michael King, Investor Relations 
 
 Consilium Strategic Communications           Tel: [phone] 
                                                              5700 
 Matthew Neal / Lucy Featherstone          [e-mail] 
 
 Investec Bank PLC (NOMAD & Broker)           Tel: [phone] 
                                                              5970 
 Gary Clarence / David Anderson 
 
 HSBC Bank PLC (Broker)                        Tel: [phone] 
                                                              8888 
 Sam McLennan / Joe Weaving / Stephanie 
  Cornish 
 

About Advanced Medical Solutions Group plc - see www.admedsol.com

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand(R) , RESORBA(R) , LiquiBandFix8(R) and Seal-G(R) . AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal(R) brand as well as under white label. Since 2019, the Group has made five acquisitions: Sealantis, an Israeli developer of innovative internal sealants; Biomatlante, a French developer and manufacturer of surgical biomaterials, Raleigh, a leading UK coater and converter of woundcare and bio-diagnostics materials, AFS Medical, an Austrian specialist surgical business and Connexicon, an Irish tissue adhesives specialist.

AMS's products, manufactured in the UK, Germany, France, the Netherlands, the Czech Republic and Israel, are sold globally via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Austria, Germany, the Czech Republic and Russia. The Group has R&D innovation hubs in the UK, Ireland, Germany, France and Israel. Established in 1991, the Group has more than 800 employees. For more information, please see www.admedsol.com .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGFLFIVEVILVIV

(END) Dow Jones Newswires

May 31, 2023 09:08 ET (13:08 GMT)